At the time of writing, Amneal Pharmaceuticals Inc [AMRX] stock is trading at $8.81, up 3.28%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AMRX shares have gain 6.79% over the last week, with a monthly amount glided 4.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amneal Pharmaceuticals Inc [NASDAQ: AMRX] stock has seen the most recent analyst activity on September 06, 2024, when JP Morgan upgraded its rating to a Neutral but kept the price target unchanged to $9 for it. On March 08, 2021, upgrade upgraded it’s rating to Buy and revised its price target to $6.50 on the stock. Guggenheim upgraded its rating to a Buy but stick to its price target of $5.50 on December 14, 2020. Barclays upgraded its rating to a Overweight and raised its price target to $6 on December 14, 2020. Goldman started tracking with a Sell rating for this stock on July 27, 2020, and assigned it a price target of $4. In a note dated May 12, 2020, Guggenheim upgraded an Neutral rating on this stock.
For the past year, the stock price of Amneal Pharmaceuticals Inc fluctuated between $4.46 and $9.48. Currently, Wall Street analysts expect the stock to reach $11.5 within the next 12 months. Amneal Pharmaceuticals Inc [NASDAQ: AMRX] shares were valued at $8.81 at the most recent close of the market. An investor can expect a potential return of 30.53% based on the average AMRX price forecast.
Analyzing the AMRX fundamentals
According to Amneal Pharmaceuticals Inc [NASDAQ:AMRX], the company’s sales were 2.68B for trailing twelve months, which represents an 13.29% jump. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is 3.79 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -27.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.58 points at the first support level, and at 8.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.94, and for the 2nd resistance point, it is at 9.06.
Ratios To Look Out For
It is important to note that Amneal Pharmaceuticals Inc [NASDAQ:AMRX] has a current ratio of 1.38. As well, the Quick Ratio is 0.84, while the Cash Ratio is 0.07. Considering the valuation of this stock, the price to sales ratio is 1.02.
Transactions by insiders
Recent insider trading involved Kiely John, Director, that happened on Nov 22 ’24 when 17058.0 shares were sold. Director, Autor Deborah M. completed a deal on Nov 22 ’24 to sell 33229.0 shares. Meanwhile, Director Autor Deborah M. sold 6771.0 shares on Nov 21 ’24.
